Age: Participants aged 18–70 years; Diagnosis: Participants with T2DM; Treatment: Participants who were treated with insulin therapy; BMI: Participants with a BMI of ≥30 kg/m2. This evidence concerns the gene INS and type 2 diabetes mellitus.